UM171とKBTBD4の新型がん変異の収束メカニズム
Xiaowen Xie1,2, Olivia Zhang3,4, Megan J R Yeo3,4
1Department of Pharmacology, University of Washington, Seattle, WA, USA.
Nature
|February 12, 2025
まとめ
KBTBD4の癌変異は,タンパク質の相互作用を変化させ,髄芽細胞腫を誘発する. これらの変異は,新たに特定されたHDAC1/ 2との相互作用により,トランスクリプションのコアプレッサーであるCoRESTの異常な劣化を引き起こす. この発見は 子どもの脳腫瘍に対する 新しい治療目標を提供します
科学分野:
- 腫瘍学
- 分子生物学
- 構造生物学
背景:
- 癌の変異は 異常な細胞機能を駆動する 新種のタンパク質相互作用を生み出します
- CULLIN3- RING E3ユビキチンリガース複合体の基板受容体であるKBTBD4は,髄芽細胞腫で頻繁に変異し,機能の獲得につながります.
- これらのKBTBD4変異は,トランスクリプションのコアプレッサーであるCoRESTの分解を誘導するが,その背後にあるメカニズムは不明であった.
研究 の 目的:
- KBTBD4 変異が CoREST 退化を促進するメカニズムを解明する.
- 骨髄芽細胞腫における KBTBD4 変異の構造的および機能的影響を特徴づける.
- KBTBD4- HDAC1の相互作用を標的とした潜在的な治療戦略を特定する.
主な方法:
- KBTBD4 がんのホットスポットを マッピングする
- LSD1-HDAC1-CoRESTに結合したKBTBD4変異体の構造を決定するための冷凍電子顕微鏡.
- タンパク質の相互作用と細胞増殖に対する突然変異の影響を評価する in vitro 試験.
主要な成果:
- KBTBD4の変異は,HDAC1/2を直接ターゲットにすることで,CoRESTの分解を促進します.
- 深層変異スキャンは 特定の変異の好みを明らかにし 機能の獲得を促しました
- クリオ- EM構造では,KBTBD4ホモダイマーがHDAC1に非対称的に結合し,HDAC1活性部位に挿入することでインターフェースを安定させることが示された.
- 分子接着剤UM171とHDAC1/ 2阻害剤は,突然変異したKBTBD4- HDAC1の相互作用を妨害し,がん細胞の増殖を阻害することで治療的可能性を示した.
結論:
- KBTBD4の変異は,HDAC1/ 2との新型相互作用によって髄芽細胞腫を駆動し,CoRESTの退化につながる.
- 構造的および変異的分析は,この異常な相互作用をターゲットにするためのメカニズム的基礎を提供します.
- KBTBD4-HDAC1インターフェースを阻害剤または分子接着剤で標的化することは,KBTBD4-変異性髄芽細胞腫の有望な治療法です.
さらに関連する動画
15:05Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
8.5K
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
14.2K
関連する概念動画
Mismatch Repair
4.7K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.7K
Cancers Originate from Somatic Mutations in a Single Cell
11.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.4K
Base Excision Repair
21.9K
One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
The first step of...
21.9K
Gene Conversion
9.6K
Other than maintaining genome stability via DNA repair, homologous recombination plays an important role in diversifying the genome. In fact, the recombination of sequences forms the molecular basis of genomic evolution. Random and non-random permutations of genomic sequences create a library of new amalgamated sequences. These newly formed genomes can determine the fitness and survival of cells. In bacteria, homologous and non-homologous types of recombination lead to the evolution of new...
9.6K
Mutations
78.6K
Overview
78.6K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
